1 Product identity
Ingredient risk
2 ingredients to use with caution
Vitamin B1 High Potency 500 mg
BrandBIOVEA→Single Vitamin and Mineral Tablet or Pill 9 ingredients 2 caution DSLD #209107Net contents: 50 Vegetarian Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2019-11-21
2 Ingredients (9)
IngredientGroupSafety
Stearic AcidStearic Acid—
powdered CelluloseCellulose—
White Aqueous CoatingCoating—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Thiamin — Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patie…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Thiamin — Use with Caution
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID209107
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2019-11-21
6 More from BIOVEA
View BIOVEA Safety Scorecard → 91 products
Acai 750 mgAcerola 500 mgAloe Vera Juice UnflavouredAntioxidant ComplexArtichoke Extract 500 mgBCAA7 Cite this page
Vancouver
Pkhakadze G. Vitamin B1 High Potency 500 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 31]. Available from: https://supplement.ge/products/vitamin-b1-high-potency-500-mg-209107/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG